VLA has 2 posters including a presentation again on MITCI at ASCO on the 5th June.
Hopefully, we'll get a bit more of an update on the progress of both trials.
Abstract 3014
Activity of a novel immunotherapy combination of intralesional CoxsackievirusA21 and systemic ipilimumab in advanced melanoma patients previously treated with anti-PD1 blockade therapy.
Poster Board: #109
Discussed at the Poster Discussion Session on Monday, June 5, 2017, 4:45 PM - 6:00 PM, at Hall D1
Brendan D. Curti - First Author
Providence Cancer Center and Earle A. Chiles Research Institute
Abstract TPS3108
Keynote-200 phase 1b: A novel combination study of intravenously delivered coxsackievirus A21 and pembrolizumab in advanced cancer patients.
Poster Board: #194b
Hardev S. Pandha, MD, PhD - First Author
University of Surrey
https://iplanner.asco.org/am2017/#/
Search for "A21"
.
ASCO 2017
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)